154 related articles for article (PubMed ID: 17333484)
1. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors.
Marrero-Ponce Y; Khan MT; Casañola-Martín GM; Ather A; Sultankhodzhaev MN; García-Domenech R; Torrens F; Rotondo R
J Comput Aided Mol Des; 2007 Apr; 21(4):167-88. PubMed ID: 17333484
[TBL] [Abstract][Full Text] [Related]
2. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
[TBL] [Abstract][Full Text] [Related]
3. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
Marrero-Ponce Y; Khan MT; Casañola Martín GM; Ather A; Sultankhodzhaev MN; Torrens F; Rotondo R
ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
[TBL] [Abstract][Full Text] [Related]
4. Bond-based 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation.
Casañola-Martin GM; Marrero-Ponce Y; Khan MT; Khan SB; Torrens F; Pérez-Jiménez F; Rescigno A; Abad C
Chem Biol Drug Des; 2010 Dec; 76(6):538-45. PubMed ID: 20964806
[TBL] [Abstract][Full Text] [Related]
5. Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database.
Le-Thi-Thu H; Casañola-Martín GM; Marrero-Ponce Y; Rescigno A; Saso L; Parmar VS; Torrens F; Abad C
Mol Divers; 2011 May; 15(2):507-20. PubMed ID: 20814821
[TBL] [Abstract][Full Text] [Related]
6. Atom- and bond-based 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors.
Casañola-Martín GM; Marrero-Ponce Y; Tareq Hassan Khan M; Torrens F; Pérez-Giménez F; Rescigno A
J Biomol Screen; 2008 Dec; 13(10):1014-24. PubMed ID: 19015291
[TBL] [Abstract][Full Text] [Related]
7. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
[TBL] [Abstract][Full Text] [Related]
8. New tyrosinase inhibitors selected by atomic linear indices-based classification models.
Casañola-Martín GM; Khan MT; Marrero-Ponce Y; Ather A; Sultankhodzhaev MN; Torrens F
Bioorg Med Chem Lett; 2006 Jan; 16(2):324-30. PubMed ID: 16275084
[TBL] [Abstract][Full Text] [Related]
9. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
11. Vanilloid derivatives as tyrosinase inhibitors driven by virtual screening-based QSAR models.
Rescigno A; Casañola-Martin GM; Sanjust E; Zucca P; Marrero-Ponce Y
Drug Test Anal; 2011 Mar; 3(3):176-81. PubMed ID: 21125547
[TBL] [Abstract][Full Text] [Related]
12. Tetraketones: a new class of tyrosinase inhibitors.
Khan KM; Maharvi GM; Khan MT; Jabbar Shaikh A; Perveen S; Begum S; Choudhary MI
Bioorg Med Chem; 2006 Jan; 14(2):344-51. PubMed ID: 16198580
[TBL] [Abstract][Full Text] [Related]
13. Antiprotozoan lead discovery by aligning dry and wet screening: prediction, synthesis, and biological assay of novel quinoxalinones.
Martins Alho MA; Marrero-Ponce Y; Barigye SJ; Meneses-Marcel A; Machado Tugores Y; Montero-Torres A; Gómez-Barrio A; Nogal JJ; García-Sánchez RN; Vega MC; Rolón M; Martínez-Fernández AR; Escario JA; Pérez-Giménez F; Garcia-Domenech R; Rivera N; Mondragón R; Mondragón M; Ibarra-Velarde F; Lopez-Arencibia A; Martín-Navarro C; Lorenzo-Morales J; Cabrera-Serra MG; Piñero J; Tytgat J; Chicharro R; Arán VJ
Bioorg Med Chem; 2014 Mar; 22(5):1568-85. PubMed ID: 24513185
[TBL] [Abstract][Full Text] [Related]
14. QuBiLS-MAS, open source multi-platform software for atom- and bond-based topological (2D) and chiral (2.5D) algebraic molecular descriptors computations.
Valdés-Martiní JR; Marrero-Ponce Y; García-Jacas CR; Martinez-Mayorga K; Barigye SJ; Vaz d'Almeida YS; Pham-The H; Pérez-Giménez F; Morell CA
J Cheminform; 2017 Jun; 9(1):35. PubMed ID: 29086120
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship studies of mushroom tyrosinase inhibitors.
Xue CB; Luo WC; Ding Q; Liu SZ; Gao XX
J Comput Aided Mol Des; 2008 May; 22(5):299-309. PubMed ID: 18256890
[TBL] [Abstract][Full Text] [Related]
16. Predictive models for tyrosinase inhibitors: Challenges from heterogeneous activity data determined by different experimental protocols.
Tang H; Cui F; Liu L; Li Y
Comput Biol Chem; 2018 Apr; 73():79-84. PubMed ID: 29471263
[TBL] [Abstract][Full Text] [Related]
17. Tyrosinase inhibition: conformational analysis based studies on molecular dynamics calculations of bipiperidine based inhibitors.
Khan KM; Saify ZS; Khan MT; Butt N; Maharvi GM; Perveen S; Ambreen N; Choudhary MI; Atta-Ur-Rahman ; Supuran CT
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):401-7. PubMed ID: 16206837
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.
Marrero-Ponce Y; Siverio-Mota D; Gálvez-Llompart M; Recio MC; Giner RM; García-Domènech R; Torrens F; Arán VJ; Cordero-Maldonado ML; Esguera CV; de Witte PA; Crawford AD
Eur J Med Chem; 2011 Dec; 46(12):5736-53. PubMed ID: 22000935
[TBL] [Abstract][Full Text] [Related]
19. Bond-based linear indices in QSAR: computational discovery of novel anti-trichomonal compounds.
Marrero-Ponce Y; Meneses-Marcel A; Rivera-Borroto OM; García-Domenech R; De Julián-Ortiz JV; Montero A; Escario JA; Barrio AG; Pereira DM; Nogal JJ; Grau R; Torrens F; Vogel C; Arán VJ
J Comput Aided Mol Des; 2008 Aug; 22(8):523-40. PubMed ID: 18483767
[TBL] [Abstract][Full Text] [Related]
20. In silico modelling of azole derivatives with tyrosinase inhibition ability: Application of the models for activity prediction of new compounds.
De B; Adhikari I; Nandy A; Saha A; Goswami BB
Comput Biol Chem; 2018 Jun; 74():105-114. PubMed ID: 29574329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
